Page last updated: 2024-09-04

amotosalen and Congenital Thrombotic Thrombocytopenic Purpura

amotosalen has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coppo, P; Corash, L; Garraud, O; Herbrecht, R; Lin, JS; Liu, K; Malot, S; Ojeda-Uribe, M; Payrat, JM; Veyradier, A1
Corash, L; Lawrie, AS; Machin, SJ; Mackie, IJ; Pinkoski, L; Yarranton, H1
Kiss, JE1
Benjamin, RJ; Conlan, MG; Corash, L; Crookston, KP; Damon, L; George, J; Goodnough, LT; Hillyer, C; Kessler, C; Lin, JS; Lopez-Plaza, I; MacKenzie, M; McCrae, K; Menitove, JE; Mintz, PD; Neff, A; Rouault, C; Skikne, BS1

Trials

1 trial(s) available for amotosalen and Congenital Thrombotic Thrombocytopenic Purpura

ArticleYear
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
    Transfusion, 2006, Volume: 46, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Child; Disease-Free Survival; Double-Blind Method; Female; Furocoumarins; Humans; Infection Control; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Remission Induction; Time Factors; Ultraviolet Rays

2006

Other Studies

3 other study(ies) available for amotosalen and Congenital Thrombotic Thrombocytopenic Purpura

ArticleYear
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2019, Volume: 58, Issue:6

    Topics: Adult; Cohort Studies; Detergents; Female; Furocoumarins; Humans; Male; Plasma; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Solvents; Treatment Outcome

2019
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light.
    Transfusion, 2005, Volume: 45, Issue:9

    Topics: Bacterial Infections; Blood Coagulation Factors; Blood Proteins; Cryopreservation; Furocoumarins; Hemostasis; Humans; In Vitro Techniques; Photochemistry; Plasma; Purpura, Thrombotic Thrombocytopenic; Ultraviolet Rays

2005
Randomized clinical trials in thrombotic thrombocytopenic purpura: where do we go from here?
    Transfusion, 2006, Volume: 46, Issue:10

    Topics: Disease-Free Survival; Double-Blind Method; Female; Furocoumarins; Humans; Infection Control; Male; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Ultraviolet Rays

2006